The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Biochemical safety profiles of gadolinium‐based extracellular contrast agents and nephrogenic systemic fibrosis
Open accessAbstract
Gadolinium (Gd)‐based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd‐based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side effects and adverse reactions from Gd is now an important requirement for practicing radiologists. In addition to the ongoing accumulation and analyses of clinical NSF data, it is also essential for the practicing radiologist to understand the biochemical characteristics of the extracellular Gd‐chelates. The purpose of this review is to consolidate and update the available information on known side effects, adverse reactions, and toxicity of the Gd chelates, with particular emphasis on the potential mechanisms of NSF. J. Magn. Reson. Imaging 2007;26:1190–1197. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,859
Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060601 · Cited by 1,400
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,018
Biochemistry of the Lanthanides
Evans, C. H. (1990) · Springer eBooks · doi:10.1007/978-1-4684-8748-0 · Cited by 639
Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis
Kuo, P. H., Kanal, E., Abu-Alfa, A. K., & Cowper, S. E. (2007) · Radiology · doi:10.1148/radiol.2423061640 · Cited by 630
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 604
The use of iodinated and gadolinium contrast media during pregnancy and lactation
Webb, J. A. W., Thomsen, H. S., Morcos, S. K., & Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) · European Radiology · doi:10.1007/s00330-004-2583-y · Cited by 590
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
High, W. A., Ayers, R. A., Chandler, J., Zito, G., & Cowper, S. E. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.047 · Cited by 545
Laurent, S., Elst, L. V., & Muller, R. N. (2006) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.100 · Cited by 441
The relationship between thermodynamics and the toxicity of gadolinium complexes
Cacheris, W. P., Quay, S. C., & Rocklage, S. M. (1990) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(90)90055-7 · Cited by 436
Nephrotoxicity of high‐dose gadolinium compared with iodinated contrast
Prince, M. R., Arnoldus, C., & Frisoli, J. K. (1996) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880060129 · Cited by 398
Idée, J., Port, M., Raynal, I., Schaefer, M., Le Greneur, S., & Corot, C. (2006) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00447.x · Cited by 395
Gadolinium deposition in nephrogenic fibrosing dermopathy
Boyd, A. S., Zic, J. A., & Abraham, J. L. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.048 · Cited by 373
White, G. W., Gibby, W. A., & Tweedle, M. F. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000186569.32408.95 · Cited by 362
Trends in Adverse Events After IV Administration of Contrast Media
Cochran, S. T., Bomyea, K., & Sayre, J. W. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.176.6.1761385 · Cited by 358
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Thomsen, H. S. (2006) · European Radiology · doi:10.1007/s00330-006-0495-8 · Cited by 352
Adverse reactions to gadolinium contrast media: a review of 36 cases.
Murphy, K. J., Brunberg, J. A., & Cohan, R. H. (1996) · American Journal of Roentgenology · doi:10.2214/ajr.167.4.8819369 · Cited by 276
Deo, A., Fogel, M., & Cowper, S. E. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03921106 · Cited by 259
MR contrast agents: Physical and pharmacologic basics
Lin, S., & Brown, J. J. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20955 · Cited by 259
Gd-DOTA: characterization of a new paramagnetic complex.
Bousquet, J. C., Saini, S., Stark, D. D., Hahn, P. F., Nigam, M., Wittenberg, J., & Ferrucci, J. T. (1988) · Radiology · doi:10.1148/radiology.166.3.3340763 · Cited by 257
Clinical safety of gadopentetate dimeglumine.
Nelson, K. L., Gifford, L. M., Lauber-Huber, C., Gross, C. A., & Lasser, T. A. (1995) · Radiology · doi:10.1148/radiology.196.2.7617858 · Cited by 223
Safety of gadolinium contrast angiography in patients with chronic renal insufficiency
Sam, A. D., Morasch, M. D., Collins, J., Song, G., Chen, R., & Pereles, F. S. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00315-x · Cited by 213
Spinazzi, A., Lorusso, V., Pirovano, G., & Kirchin, M. (1999) · Academic Radiology · doi:10.1016/s1076-6332(99)80451-6 · Cited by 204
Case-control study of gadodiamide-related nephrogenic systemic fibrosis
Marckmann, P., Skov, L., Rossen, K., Heaf, J. G., & Thomsen, H. S. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm261 · Cited by 204
Shamam, Y. M., & Jesús, O. D. (2021) · StatPearls · Cited by 189
Contrast Agents for Magnetic Resonance Imaging: Safety Update
Kirchin, M. A., & Runge, V. M. (2003) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200310000-00007 · Cited by 163
Physicochemical Properties of Gadoteridol and Other Magnetic Resonance Contrast Agents
Tweedle, M. F. (1992) · Investigative Radiology · doi:10.1097/00004424-199208001-00002 · Cited by 158
HARPUR, E. S., WORAH, D., HALS, P.-A., HOLTZ, E., FURUHAMA, K., & NOMURA, H. (1993) · Investigative Radiology · doi:10.1097/00004424-199303001-00004 · Cited by 158
Biodistribution and toxicity of MR imaging contrast media
Øksendal, A. N., & Hals, P. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030128 · Cited by 156
Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis
High, W. A., Ayers, R. A., & Cowper, S. E. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.01.022 · Cited by 149
Gadolinium Chloride Toxicity in the Rat
Spencer, A. J., Wilson, S. A., Batchelor, J. F., Reid, A., Pees, J., & Harpur, E. S. (1997) · Toxicologic Pathology · doi:10.1177/019262339702500301 · Cited by 146
Nyman, U., Elmståhl, B., Leander, P., Nilsson, M., Golman, K., & Almèn, T. (2002) · Radiology · doi:10.1148/radiol.2232010221 · Cited by 135
Electron microscopic study of Kupffer-cell phagocytosis blockade induced by gadolinium chloride.
Husztik, E., Lázár, G., & Párducz, Á. (1980) · PubMed · Cited by 131
Basic Experimental Studies and Clinical Aspects of Gadolinium Salts and Chelates
Adding, C., Bannenberg, G. L., & Gustafsson, L. E. (2001) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2001.tb00182.x · Cited by 118
PUTTAGUNTA, N. R., Gibby, W. A., & SMITH, G. T. (1996) · Investigative Radiology · doi:10.1097/00004424-199612000-00001 · Cited by 108
Safety and Pharmacokinetic Profile of Gadobenate Dimeglumine in Subjects With Renal Impairment
Swan, S. K., Lambrecht, L. J., Townsend, R. R., DAVIES, B. E., McCLOUD, S., PARKER, J. R., Bensel, K. S., & LaFrance, N. D. (1999) · Investigative Radiology · doi:10.1097/00004424-199907000-00001 · Cited by 97
Briguori, C., Colombo, A., Airoldi, F., Melzi, G., Michev, I., Carlino, M., Montorfano, M., Chieffo, A., Bellanca, R., & Ricciardelli, B. (2006) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.20592 · Cited by 95
Magnetic Resonance Imaging Contrast Agents Design and Physicochemical Properties of Gadodiamide
Chang, C. A. (1993) · Investigative Radiology · doi:10.1097/00004424-199303001-00003 · Cited by 89
MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver
Spinazzi, A., Lorusso, V., Pirovano, G., Taroni, P., Kirchin, M. A., & Davies, A. (1998) · Academic Radiology · doi:10.1016/s1076-6332(98)80069-x · Cited by 80
WAGONER, M. V., O'toole, M., Worah, D., et al. (1991) · Investigative Radiology · doi:10.1097/00004424-199111000-00010 · Cited by 79
Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
Bongartz, G. (2007) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-007-0071-5 · Cited by 51
Gadolinium Magnetic Resonance Contrast Agents Produce Analytic Interference in Multiple Serum Assays
Proctor, K. A. S., Rao, L. V., & Roberts, W. L. (2004) · American Journal of Clinical Pathology · doi:10.1309/mga3lc4x8cglx9ch · Cited by 49
GD-DOTA: Evaluation of its renal tolerance in patients with chronic renal failure
Bellin, M., Deray, G., Assogba, U., Auberton, E., Ghany, F., Dion, É., Jacobs, C., & Grellet, J. (1992) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(92)90380-i · Cited by 47
Dermal and extra-dermal manifestations of gadolinium-triggered nephrogenic fibrosing dermopathy
Stöllberger, C., & Finsterer, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl592 · Cited by 17
Pirovano, G., Goodman, D. B., Halemane, U., Venetianer, C., Kirchin, M. A., & Spinazzi, A. (2004) · Radiology · doi:10.1148/radiol.2332031802 · Cited by 7
Cited by
Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine
Akbarzadeh, A., Samiei, M., & Davaran, S. (2012) · Nanoscale Research Letters · doi:10.1186/1556-276x-7-144 · Cited by 1,241
Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications
Lu, K., Aung, T., Guo, N., Weichselbaum, R., & Lin, W. (2018) · Advanced Materials · doi:10.1002/adma.201707634 · Cited by 692
Villaraza, A. J. L., Bumb, A., & Brechbiel, M. W. (2010) · Chemical Reviews · doi:10.1021/cr900232t · Cited by 632
Harnessing albumin as a carrier for cancer therapies
Hoogenboezem, E. N., & Duvall, C. L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.011 · Cited by 610
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 604
Metadata
- Authors
- Ersoy, H., & Rybicki, F. J.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2007-10-29
- Volume
- 26
- Issue
- 5
- Pages
- 1190-1197
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W1963655497
- Cited by
- 283
- References
- 45
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.